Wellfully Ltd Cash Flow Conversion Efficiency
Wellfully Ltd cash flow conversion efficiency. Based on the latest financial reports, Wellfully Ltd (WFL) has a cash flow conversion efficiency ratio of -0.017x as of December 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$28.49K ≈ $20.16K USD) by net assets (AU$-1.69 Million ≈ $-1.19 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Wellfully Ltd for the company's overall valuation and market capitalisation.
Cash Flow Conversion Efficiency of Wellfully Ltd (2015–2022)
Cash flow conversion efficiency of Wellfully Ltd from 2015 to 2022. This chart illustrates how Wellfully Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View WFL stock price for real-time trading data and today's change.
Wellfully Ltd Cash Flow Conversion Ratio Explained
Wellfully Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Wellfully Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Wellfully Ltd ranked by their cash flow conversion efficiency. Review WFL cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Anpario Plc
LSE:ANP
|
0.112x |
|
ENGAGE XR HLDGS EO-001
F:6VR
|
N/A |
|
Team Internet Group PLC
LSE:TIG
|
0.091x |
|
Audioboom Group plc
LSE:BOOM
|
0.076x |
|
Semilux International Ltd. Ordinary Shares
NASDAQ:SELX
|
-0.064x |
|
POLAREAN IMAG.LS-00037
F:8ZF
|
N/A |
|
Robert Walters
LSE:RWA
|
0.002x |
|
Suumaya Industries Limited
NSE:SUULD
|
-0.016x |
Annual Cash Flow Conversion Efficiency for Wellfully Ltd (2015–2022)
The table below shows the annual cash flow conversion efficiency of Wellfully Ltd from 2015 to 2022. Also see Wellfully Ltd assets under control for a full breakdown of the balance sheet.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2022-12-31 | AU$-1.71 Million ≈ $-1.21 Million |
AU$-2.44 Million ≈ $-1.73 Million |
1.429x | +110.73% |
| 2021-12-31 | AU$619.56K ≈ $438.38K |
AU$-8.25 Million ≈ $-5.84 Million |
-13.314x | -490.90% |
| 2020-12-31 | AU$2.31 Million ≈ $1.63 Million |
AU$-5.20 Million ≈ $-3.68 Million |
-2.253x | -202.62% |
| 2019-12-31 | AU$-1.22 Million ≈ $-862.54K |
AU$-2.68 Million ≈ $-1.89 Million |
2.196x | +397.85% |
| 2018-12-31 | AU$2.55 Million ≈ $1.80 Million |
AU$-1.88 Million ≈ $-1.33 Million |
-0.737x | -119.71% |
| 2017-12-31 | AU$4.26 Million ≈ $3.01 Million |
AU$-1.43 Million ≈ $-1.01 Million |
-0.336x | -13.45% |
| 2016-12-31 | AU$5.70 Million ≈ $4.03 Million |
AU$-1.69 Million ≈ $-1.19 Million |
-0.296x | +4.03% |
| 2015-12-31 | AU$7.28 Million ≈ $5.15 Million |
AU$-2.24 Million ≈ $-1.59 Million |
-0.308x | -- |
About Wellfully Ltd
Wellfully Limited, together with its subsidiaries, engages in the research and development of Dermaportation and ETP transdermal drug delivery technologies. The company operates through two segments, Dermaportation Drug Delivery Technology and Devices. It is involved in the industrialization and supply-chain support for its existing product ranges; and sale and marketing of its own brands REDUIT … Read more